OncoC4
Investors
Venture capital firms, private equity investors, and strategic partners
| Investor | Type |
|---|---|
3E Bioventures Capital | Other |
Greater Bay Area Homeland | Other |
Kaitai Capital | N/A |
National Institutes of Health | Other |
Common Investor Types
- •Venture Capital Firms: Early-stage and growth equity investors
- •Private Equity: Later-stage institutional investors
- •Strategic Investors: Corporations in related industries
- •Angel Investors: High-net-worth individuals
- •Family Offices: Private wealth management firms
What Investors Provide
- ✓Capital for growth and expansion
- ✓Strategic guidance and expertise
- ✓Industry connections and partnerships
- ✓Market validation and credibility
- ✓Board representation and governance
Who Invested in OncoC4?
OncoC4 has attracted investment from 4+ venture capital firms, private equity investors, and strategic partners across 0 funding rounds. These investors have provided a total of $50M in capital to fuel the company's growth.
Why Do Investors Fund OncoC4?
Investors are attracted to OncoC4 due to the company's strong market position, growth potential, and proven business model. The company's current valuation of $660M reflects investor confidence in its ability to generate returns through continued growth, potential IPO, or strategic acquisition.
Types of OncoC4 Investors
OncoC4 investors typically include a mix of venture capital firms providing growth capital, private equity firms for later-stage funding, strategic corporate investors from related industries, and high-net-worth angel investors. Each investor type brings unique value beyond capital, including industry expertise, strategic partnerships, and operational guidance.
Investor FAQs
How many investors does OncoC4 have?
OncoC4 has had 4+ investors participate across its funding rounds. This includes venture capital firms, private equity investors, strategic partners, and angel investors.
Who are the lead investors in OncoC4?
Lead investors typically invest the largest amounts and often take board seats. For detailed information about OncoC4's lead investors and cap table structure, please contact our team.
Can I become an investor in OncoC4?
Accredited investors can purchase OncoC4 shares on the secondary market through Premier Alternatives. This provides an opportunity to invest in the company before a potential IPO or acquisition event.